TAKAYASU, K.; MUGURUMA, K.; KINOSHITA, H. Durable complete response to combination nivolumab and ipilimumab in metastatic renal cell carcinoma. Trends in Immunotherapy, [S. l.], v. 6, n. 1, 2022. DOI: 10.24294/ti.v6.i1.1387. Disponível em: http://ojs.ukscip.com/index.php/ti/article/view/426. Acesso em: 4 sep. 2025.